Literature DB >> 3384753

Mode of action of deoxypheganomycin D on Mycobacterium smegmatis ATCC 607.

K Suzukake-Tsuchiya1, M Hori, N Shimada, M Hamada.   

Abstract

Deoxypheganomycin D, a specific inhibitor of mycobacteria, inhibits the growth in vitro of Mycobacterium smegmatis ATCC 607 (M. 607) bacteriostatically at concentrations as high as 7 X 10(-5) M. It shows no cross-resistance to paromomycin, capreomycin, viomycin, streptothricin, kanamycin and streptomycin. Deoxypheganomycin D at 2.8 X 10(-7) M where the cell growth of M. 607 is only partially inhibited does not significantly inhibit DNA, RNA or protein synthesis but leads to marked decrease (13% of control) in [14C]glycerol-derived radioactivity in cell-walls. In the presence of 7 X 10(-6) M deoxypheganomycin D, the influx of leucine but not thymidine is affected while the reverse is true with efflux. The data suggest that the effect of deoxypheganomycin D on M. 607 may be related to both the cell membrane and specific mycobacterial lipid like components of the cell-wall.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3384753     DOI: 10.7164/antibiotics.41.675

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  2 in total

1.  Structure and activity relationships of the anti-Mycobacterium antibiotics resorcinomycin and pheganomycin.

Authors:  Yasushi Ogasawara; Koichi Ooya; Michiko Fujimori; Motoyoshi Noike; Tohru Dairi
Journal:  J Antibiot (Tokyo)       Date:  2015-08-26       Impact factor: 2.649

2.  A peptide ligase and the ribosome cooperate to synthesize the peptide pheganomycin.

Authors:  Motoyoshi Noike; Takashi Matsui; Koichi Ooya; Ikuo Sasaki; Shouta Ohtaki; Yoshimitsu Hamano; Chitose Maruyama; Jun Ishikawa; Yasuharu Satoh; Hajime Ito; Hiroyuki Morita; Tohru Dairi
Journal:  Nat Chem Biol       Date:  2014-11-24       Impact factor: 15.040

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.